Lewis is a partner of Dechert’s Hong Kong office. He assists life sciences and technology companies, and their financial sponsors to capture, manage, risk assess, evaluate, and monetize their IP assets. His practice focuses on enforcing IPrights and structuring technology transactions. Lewis is ranked as one of Top 15 IP Lawyers in China by ALB 2015. He has been recognized consistently by legal directories and publications, including Chambers, Legal 500 and IAM, as a leading IP, life sciences, patent litigation and technology transactions lawyer in China. Lewis handled a wide range of litigation and strategic patent matters for technology companies in global patent infringement and antitrust litigations, FRAND obligations and licensing disputes. He also represented pharmaceutical companies in relation to patent infringement and regulatory actions against generics and biosimilar in China.